BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Treatment
422 results:

  • 1. egfr and PI3K Signalling Pathways as Promising Targets on Circulating Tumour Cells from Patients with Metastatic gastric Adenocarcinoma.
    Piper AK; Penney C; Holliday J; Tincknell G; Ma Y; Napaki S; Pantel K; Brungs D; Ranson M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791602
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Targeted plasma proteomic analysis uncovers a high-performance biomarker panel for early diagnosis of gastric cancer.
    Feng T; Jie M; Deng K; Yang J; Jiang H
    Clin Chim Acta; 2024 May; 558():119675. PubMed ID: 38631604
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Natural Peptide from A Traditional Chinese Medicine Has the Potential to Treat Chronic Atrophic Gastritis by Activating gastric Stem Cells.
    Li K; Ma X; Li Z; Liu Y; Shen G; Luo Z; Wang D; Xia L; Wang Z; Tian M; Liu H; Geng F; Li B
    Adv Sci (Weinh); 2024 May; 11(20):e2304326. PubMed ID: 38544338
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Circular RNA CircSLC22A23 Promotes gastric cancer Progression by Activating HNRNPU Expression.
    Wu X; Cao C; Li Z; Xie Y; Zhang S; Sun W; Guo J
    Dig Dis Sci; 2024 Apr; 69(4):1200-1213. PubMed ID: 38400886
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Elucidating molecular mechanisms and therapeutic synergy: irreversible HER2-TKI plus T-Dxd for enhanced anti-HER2 treatment of gastric cancer.
    Liu J; Zhu T; Zhao R; Ren W; Zhao F; Liu J
    Gastric Cancer; 2024 May; 27(3):495-505. PubMed ID: 38386239
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Modified Chaishao Liujunzi Decoction inhibits bile acid-induced gastric intestinal metaplasia: from network prediction to experimental verification.
    Sun Z; Liu Y; Deng H; Wang S; Zhang J; Xing C; Xu C
    Aging (Albany NY); 2023 Dec; 15(23):13998-14018. PubMed ID: 38096029
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Future of HER2-Targeted treatment for Osteosarcoma: Lessons from the Negative Trastuzumab Deruxtecan Results.
    Nakano K
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069146
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Network pharmacology‑based investigation of potential targets of triptonodiol acting on non-small-cell lung cancer.
    Jin F; Ni X; Yu S; Jiang X; Zhou J; Mao D; Liu Y; Wu F
    Eur J Med Res; 2023 Nov; 28(1):547. PubMed ID: 38017514
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line treatment of Advanced gastric cancer: K-Umbrella gastric cancer Study.
    Lee CK; Kim HS; Jung M; Kim H; Bae WK; Koo DH; Jeung HC; Park SR; Hwang IG; Zang DY; Lee HW; Park S; Nam CM; Chung HC; Rha SY
    J Clin Oncol; 2024 Jan; 42(3):348-357. PubMed ID: 37883723
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Mechanism of Astragali Radix-Curcumae Rhizoma in treating gastric cancer based on network pharmacology and experimental verification].
    Tan XY; Tao J; Zhang Y; Gu RX
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5056-5067. PubMed ID: 37802848
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Gancao Xiexin Decoction inhibits gastric carcinoma proliferation and migration by regulating the JAK2/STAT3 signalling pathway.
    Yang Y; Yuan L; Meng F; Lu D; Che M; Zhou X; Chen G; Ning N; Nan Y
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117241. PubMed ID: 37777026
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
    Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
    Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cardiorespiratory fitness and BMI measured in youth and 5-year mortality after site-specific cancer diagnoses in men-A population-based cohort study with register linkage.
    Onerup A; Mehlig K; Ekblom-Bak E; Lissner L; Börjesson M; Åberg M
    Cancer Med; 2023 Oct; 12(19):20000-20014. PubMed ID: 37732468
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs.
    Pace A; Scirocchi F; Napoletano C; Zizzari IG; Po A; Megiorni F; Asquino A; Pontecorvi P; Rahimi H; Marchese C; Ferretti E; Nuti M; Rughetti A
    J Transl Med; 2023 Sep; 21(1):626. PubMed ID: 37715207
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The disappearance of gastric metastasis and liver metastasis in non-small cell lung adenocarcinoma is due to osimertinib.
    Wang Y; Yan C; Zhang C; Yu E; Wang K; Liu X; Yu J; Zhou C; Yang A
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):16069-16073. PubMed ID: 37695388
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
    Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
    Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Skip metastasis at the esophageal resection margin in radical gastrectomy: clinical characteristics of 30 cases].
    Liu S; Xia QY; Fu Y; Lu XF; Wang M; Guan WX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):675-679. PubMed ID: 37583025
    [No Abstract]    [Full Text] [Related]  

  • 18. The first Middle East and North Africa expert consensus recommendations for management of advanced gastric cancer.
    Kourie HR; Mahrous M; Naim N; Zouein J; Benbrahim Z; Rasul K; Mokhtar M; Shehri AA; Shakeeb M; Khatib S; Al-Shamsi H; Shamseddine A; Smyth E
    Future Oncol; 2023 Jul; 19(21):1451-1459. PubMed ID: 37526151
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Exploring the Potential Mechanism of Action of Ursolic Acid against gastric cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
    Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
    Curr Pharm Des; 2023; 29(16):1274-1292. PubMed ID: 37218202
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
    Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
    Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 22.